UN panel recommends stricter patentability rules and compulsory licensing to improve access to medicine
A United Nations taskforce released its much-anticipated report on patient access to medicines this week. In the run-up to the report’s publication, many IP owners expected that the role of patents in the drug industry would very much be in the…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.